The Food and Drug Administration approved the Amphastar Pharmaceuticals-produced generic version of blood thinner Lovenox, which Watson Pharmaceuticals (WPI) will distribute. The enoxaparin sodium injection is intended as a prophylaxis and treatment for deep vein thrombosis and as prophylaxis for ischemic complications in unstable angina and non-Q-wave myocardial infarction.
Lovenox was originally developed by Sanofi-Aventis (NASDAQ:SNY). Amphastar said it will launch the product in the fourth quarter.
Shares of Momenta Pharmaceuticals (MNTA) are falling after the approval of a generic competitor to its own version of Lovenox, which it sells with Novartis’ (NYSE:NVS) Sandoz unit.
Also keep an eye on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) today. The company said late yesterday it has agreed to acquire Dublin-based Azur Pharma in an all-stock transaction. Azur markets ten specialty pharma products in the central nervous system and women’s health areas, and is expected to have $95 million to $100 million in net sales in 2011.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.
The subscription fee has been repaid many-fold
Free Email Alerts By Stock:
Launch related slideshow:
Tuesday 4/16 Insider Buying Report: SAIC, BLND
Monday 4/15 Insider Buying Report: LGVN, WDFC
Friday 4/12 Insider Buying Report: ATOS, TRDA
Nasdaq 100 Movers: TSLA, ABNB
S&P 500 Movers: EFX, GPC
Dow Movers: IBM, UNH
S&P 500 Analyst Moves: AES
Dow Analyst Moves: TRV
S&P 500 Analyst Moves: KEYS
Thursday Sector Laggards: Semiconductors, Rental, Leasing, & Royalty Stocks
Thursday Sector Leaders: General Contractors & Builders, Diagnostics
Wednesday Sector Laggards: Trucking, Waste Management Stocks
Thursday's ETF with Unusual Volume: WTAI
Thursday's ETF Movers: COPX, XSD
SH, SETH: Big ETF Inflows
Daily Dividend Report: HUM,SHW,DD,KMI,PPG
Daily Dividend Report: QCOM,PEG,ENTG,SON,CFG
Daily Dividend Report: JNJ,BK,LNT,WHR,ALLY
Fed Tapers Bond Buying
Nonfarm payroll Employment Up 175,000 in February
Initial Claims Decrease, Productivity 1.8% Annual Rate Increase in Q4
Weekly Market Wrap: August 14, 2015
Weekly Market Wrap: August 7, 2015
Weekly Market Wrap: July 31, 2015
Week Ahead Market Report: June 8, 2015
Week Ahead Market Report: May 18, 2015
Week Ahead Market Report: May 4, 2015